Molecular Heart

Provider of chemoproteomics platform for small molecule drug discovery

placeBeijing, Beijing, China calendar_todayFounded 2022 language moleculemind.com

Social engagement

Social engagement: 515 social following, 6 posts in the last 12 months — below the industry typical range.

Investor mix

8 investors on record; lead investors include Cathay Biotech, Sequoia Capital China, Lenovo Capital and Incubator Group, Shenzhen Capital Group.

Investor typeCountShare
Venture capital563%
Other / undisclosed338%

Recent activity

16 Jun 2026
Event
Biopharma and biotech companies meeting at BIO
9 Jun 2026
Product launch
MMDesign
28 May 2026
Event
The Nexus Prelude – Pre-ASCO 2026 Satellite Conference
Coming soon